Soft Tissue Sarcoma
RareCancer
Soft Tissue Sarcoma is treated with 2 medications in our database, including PCXX NEUTRAL RMS BUBBLEGUM, YONDELIS. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Ross Healthcare, Janssen. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Soft Tissue Sarcoma treatment below.
What help exists for Soft Tissue Sarcoma
4
drugs indexed
2
with copay cards
2
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Soft Tissue Sarcoma
4 totalYONDELIS
Trabectedin · Janssen
🎟💙VOTRIENT
pazopanib hydrochloride
Pazopanib
pazopanib hydrochloride
🎟💙PCXX NEUTRAL RMS BUBBLEGUM
FLUORIDE TREATMENT · Ross Healthcare
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Soft Tissue Sarcoma drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Soft Tissue Sarcoma is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →